![](https://www.portail-ie.fr/wp-content/uploads/2023/03/c9a2649d836c2053fdf8c4b2394fdfc5-2-768x512.jpg)
Are European biotechnology companies sufficiently protected?
Jean-Christophe Marcoux, consultant at IMS Health, is addressing some of the key challenges European biotechs face today, and he does it from an infowar perspective. This gives a great opportunity to understand what’s at stake, and it provides key insights on strategies that can be used. It’s also a call for action to all European players willing and able to preserve patients’ interests.